
|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
In the Spotlight April 2004
pharmaceutical science and technology innovations
Articles in this issue
over 22 years ago
Spotlight on Business Riskover 22 years ago
Vibration Technology for Active Dry-Powder Inhalersover 22 years ago
FDA Attacks Counterfeitsover 22 years ago
Synthetic Excipients Challenge All-Natural Organicsover 22 years ago
April 2004over 22 years ago
Controlled-Release Dosage Forms for Diltiazem HydrochlorideTrending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5




